Treatment for Persistent Retching
The first-line treatment for persistent retching should include ondansetron (8 mg sublingual/oral every 4-6 hours) or metoclopramide (10-20 mg orally three to four times daily), with additional supportive measures based on the underlying cause. 1, 2
Pharmacological Management
First-Line Antiemetic Options
- Ondansetron (5-HT3 receptor antagonist): 8 mg sublingual/oral every 4-6 hours during episodes of retching 1
- Metoclopramide: 10-20 mg orally three to four times daily, which works through both central and peripheral pathways 2
- Promethazine: 12.5-25 mg oral/rectal every 4-6 hours (note: more sedating than other options) 1
- Prochlorperazine: 5-10 mg every 6-8 hours or 25 mg suppository every 12 hours 1
Second-Line Options for Refractory Cases
- Haloperidol or droperidol for severe, refractory cases of retching 1
- Dexamethasone: 8-12 mg IV or PO for persistent symptoms 3
- Consider adding a benzodiazepine such as lorazepam (0.5-2 mg PO/IV/sublingual every 4-6 hours) for anxiety-associated retching 3
Approach Based on Suspected Etiology
For Chemotherapy-Induced Retching
- For high emetic risk chemotherapy: Use a three-drug regimen of 5-HT3 antagonist (ondansetron/granisetron/palonosetron) + dexamethasone + neurokinin-1 antagonist (aprepitant) 3
- For moderate emetic risk: Use a two-drug regimen of 5-HT3 antagonist + dexamethasone 3
- For breakthrough retching: Add an agent from a different drug class than what was used for prophylaxis 3
For Pregnancy-Related Retching
- First-line: Ginger (250 mg capsule 4 times daily) and vitamin B6 (pyridoxine, 10-25 mg every 8 hours) 3
- Second-line: H1-receptor antagonists such as doxylamine, promethazine, or dimenhydrinate 3
- For persistent symptoms: Consider doxylamine and pyridoxine combination (10 mg/10 mg or 20 mg/20 mg) 3
For Other Causes of Persistent Retching
- Assess for underlying causes requiring specific treatment (e.g., bowel obstruction, metabolic disorders) 1
- For gastroenteritis-related retching: Ondansetron has shown superior efficacy compared to other antiemetics 4
- For opioid-induced retching: Metoclopramide remains first-line 2
Supportive Care Measures
- Ensure adequate hydration with intravenous crystalloids if dehydration is present 1
- Consider nasogastric suction for gastric decompression in cases of severe retching or suspected bowel obstruction 1
- Implement dietary modifications: small frequent meals, bland foods, and avoiding spicy/fatty foods 3
- Monitor for electrolyte abnormalities and correct as needed 3, 1
Important Considerations and Cautions
- Monitor for QT prolongation with ondansetron and some dopamine antagonists, especially in patients with cardiac risk factors 1, 5
- Watch for extrapyramidal side effects with dopamine antagonists like metoclopramide and prochlorperazine 5, 6
- Consider the sedating effects of promethazine when selecting an antiemetic 7
- For prolonged retching, assess for thiamine deficiency and consider supplementation (200-300 mg daily) 1
- Avoid metoclopramide in young patients if possible, as they may be more susceptible to adverse effects 6
When to Consider Alternative Approaches
- If first-line treatments fail after 24-48 hours, reassess for underlying causes 1
- Consider adding a second agent with a different mechanism of action 2
- For persistent symptoms despite appropriate therapy, consider diagnostic testing to rule out structural causes (e.g., esophagogastroduodenoscopy or abdominal imaging) 1